| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA
1Correspondence: Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, UNMC Eppley Cancer Center, 985870 Nebraska Medical Center, Omaha, NE 68198-5870, USA. E-mail: sbatra{at}unmc.edu
Mucins are high-molecular-weight glycoproteins and are implicated in diverse biological functions. MUC4, a member of transmembrane mucin family, is expressed in airway epithelial cells and body fluids like saliva, tear film, ear fluid, and breast milk. In addition to its normal expression, an aberrant expression of MUC4 has been reported in a variety of carcinomas. Among various potential domains of MUC4, epidermal growth factor (EGF) -like domains are hypothesized to interact with and activate the ErbB2 receptors, suggesting an intramembrane-growth factor function for MUC4. The heavily glycosylated tandem repeat domain provides the structural rigidity to the extended extracellular region. MUC4, by virtue of its extended structure, serves as a barrier for some cell-cell and cell-extracellular matrix interactions and as a potential reservoir for certain growth factors. An intricate relationship between MUC4 and growth factor signaling is also reflected in the transcriptional regulation of MUC4. The MUC4 promoter has binding sites for different transcription factors, which are responsible for the regulation of its expression in different tissues. The interferon-
, retinoic acid, and transforming growth factor-β signaling pathways regulate MUC4 expression in a partially interdependent manner. Taken together, all of these features of MUC4 strongly support its role as a potential candidate for diagnostic and therapeutic applications in cancer and other diseases.—Chaturvedi, P., Singh, A. P., Batra, S. K. Structure, evolution, and biology of the MUC4 mucin.
Key Words: cell-cell matrix interactions • cell-extracellular matrix interactions • metastasis • receptor tyrosine kinases • HER2 • cell signaling • tumor microenvironment
This article has been cited by other articles:
|
|
 |
|
  M. Kesimer, M. Scull, B. Brighton, G. DeMaria, K. Burns, W. O'Neal, R. J. Pickles, and J. K. Sheehan Characterization of exosome-like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defense FASEB J, June 1, 2009; 23(6): 1858 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Workman, C. Sweeney, and K. L. Carraway III The Membrane Mucin Muc4 Inhibits Apoptosis Induced by Multiple Insults via ErbB2-Dependent and ErbB2-Independent Mechanisms Cancer Res., April 1, 2009; 69(7): 2845 - 2852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Klingbeil, R. Marhaba, T. Jung, R. Kirmse, T. Ludwig, and M. Zoller CD44 Variant Isoforms Promote Metastasis Formation by a Tumor Cell-Matrix Cross-talk That Supports Adhesion and Apoptosis Resistance Mol. Cancer Res., February 1, 2009; 7(2): 168 - 179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bafna, A. P. Singh, N. Moniaux, J. D. Eudy, J. L. Meza, and S. K. Batra MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells Cancer Res., November 15, 2008; 68(22): 9231 - 9238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Mimeault and S K Batra Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer Gut, October 1, 2008; 57(10): 1456 - 1468. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
